Author:
Gigerenzer Gerd,Mata Jutta,Frank Ronald
Reference22 articles.
1. Andriole, G. L., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., et al. (2009). Mortality results from a randomized prostate-cancer screening trial. The New England Journal of Medicine, 360, 1310–1319.
2. Binkowska, M., & Debski, R. (2005). Screening mammography in Polish female population aged 45 to 54. Ginekologia Polska, 76, 871–878.
3. Black, W. C., Nease, R. F., & Tosteson, A. N. A. (1995). Perceptions of breast-cancer risk and screening effectiveness in women younger than 50 years of age. Journal of the National Cancer Institute, 87, 720–731.
4. Concato, J., Wells, C. K., Horwitz, R. I., Penson, D., Fincke, G., Berlowitz, D. R., et al. (2006). The effectiveness of screening for prostate cancer: A nested case-control study. Archives of Internal Medicine, 166, 38–43.
5. Domenighetti, G., D’Avanzo, B., Egger, M., Berrino, F., Perneger, T., Mosconi, P., et al. (2003). Women’s perception of the benefits of mammography screening: Population-based survey in four countries. International Journal of Epidemiology, 32, 816–821.